Beneficial Effect of Combination Therapy Comprising Angiotensin II Receptor Blocker Plus Calcium Channel Blocker on Plasma Adiponectin Levels

被引:5
|
作者
Inoue, Yukiko [1 ]
Kakuma, Tatsuyuki [2 ]
Nonaka, Yoshisuke [2 ]
Sumi, Shunichiro [1 ]
Okamura, Keisuke [1 ]
Kodama, Sunao [1 ]
Ando, Chie [1 ]
Niimura, Hideya [1 ]
Miyoshi, Kei [1 ]
Tsuchiya, Yoshihiro [1 ]
Yamanouchi, Yoshio [1 ]
Urata, Hidenori [1 ]
机构
[1] Fukuoka Univ, Chikushi Hosp, Dept Cardiovasc Dis, Chikushino, Fukuoka 8188502, Japan
[2] Kurume Univ, Ctr Biostat, Fukuoka, Japan
关键词
ADIPOCYTE-DERIVED PROTEIN; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; ESSENTIAL-HYPERTENSION; JAPANESE POPULATION; RANDOMIZED-TRIAL; BLOOD-PRESSURE; RISK; TELMISARTAN; AMLODIPINE;
D O I
10.3109/10641960902960516
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The study aim was to examine the effect of combination therapy comprising angiotensin receptor blocker plus calcium antagonist on post-treatment plasma adiponectin levels compared to pretreatment levels. There was a significant gender difference in the relationship between preadiponectin level and age. In the search for contributing factors for treatment-based changes in adiponectin levels, these effects of gender and age were considered in statistical analysis. The adiponectin level in the combination therapy group was further increased compared to that in each of the monotherapy groups, despite there being no significant difference in antihypertensive effect, indicating that the combined medication provided an effect beyond that of lowering blood pressure.</.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [1] Effect of calcium channel blocker in combination with an angiotensin II receptor blocker in Japanese patients with hypertension
    Saruta, Takao
    DRUGS, 2006, 66 : 19 - 21
  • [2] Combination Therapy of Calcium Channel Blocker and Angiotensin II Receptor Blocker Reduces Augmentation Index in Hypertensive Patients
    Doi, Masayuki
    Miyoshi, Toru
    Hirohata, Satoshi
    Kamikawa, Shigeshi
    Usui, Shinichi
    Kaji, Youko
    Sakane, Kosuke
    Ogawa, Hiroko
    Ninomiya, Yoshifumi
    Kusachi, Shozo
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (05): : 433 - 439
  • [3] Combined Therapy With a Calcium Channel Blocker and an Angiotensin II Type 1 Receptor Blocker
    Bakris, George L.
    JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (01): : 27 - 32
  • [4] Augmentation of antiproteinuric effect by combined therapy with angiotensin II receptor blocker plus calcium channel blocker in a hypertensive patient with IgA glomerulonephritis
    Kuriyama, S
    Tomonari, H
    Abe, A
    Kunieda, T
    Hosoya, T
    JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (05) : 371 - 373
  • [5] Augmentation of antiproteinuric effect by combined therapy with angiotensin II receptor blocker plus calcium channel blocker in a hypertensive patient with IgA glomerulonephritis
    S Kuriyama
    H Tomonari
    A Abe
    T Kunieda
    T Hosoya
    Journal of Human Hypertension, 2002, 16 : 371 - 373
  • [6] BENEFICIAL EFFECT OF COMBINATION TREATMENT WITH ANGIOTENSIN II RECEPTOR BLOCKERS PLUS A CALCIUM CHANNEL BLOCKER ON AUGMENTATION INDEX IN ELDERLY PATIENTS WITH ESSENTIAL HYPERTENSION
    Doi, M.
    Miyosh, T.
    Hirohata, S.
    Kamikawa, S.
    Kaji, Y.
    Kusachi, S.
    Kusano, K.
    JOURNAL OF HYPERTENSION, 2009, 27 : S281 - S281
  • [7] The Role of Angiotensin Receptor Blocker and Calcium Channel Blocker Combination Therapy in Treating HypertensionFocus on Recent Studies
    Steven G. Chrysant
    American Journal of Cardiovascular Drugs, 2010, 10 : 315 - 320
  • [8] Effects of Exercise Therapy Alone and in Combination with a Calcium Channel Blocker or an Angiotensin Receptor Blocker in Hypertensive Patients
    Ohta, Masanori
    Tajiri, Yuji
    Yamato, Hiroshi
    Ikeda, Masaharu
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2012, 34 (07) : 523 - 529
  • [9] Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
    Volpe, Massimo
    Tocci, Giuliano
    VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 : 371 - 380
  • [10] Renoprotective effect of a calcium channel blocker, benidipine, in combination with an angiotensin II receptor blocker in hypertensive patients with chronic kidney disease
    Dohi, Y.
    Miyagawa, K.
    Nakazawa, A.
    Kimura, G.
    JOURNAL OF HYPERTENSION, 2008, 26 : S515 - S515